18 January 2024 Recce Pharmaceuticals: Phase I/II Clinical Trial Results for Diabetic Foot Infection Treatment – Positive Human Efficacy Data to Support Site Expansion 0 minute read Pharma/Biotech By Cate Swannell Previous Post Next Post